SCHEMBL17629397

SCHEMBL17629397

Oc1ccc(-c2nc(-c3ccc(Oc4ccccc4)cc3Cl)no2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HSD17B10 Q99714 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
MAPT P10636 1/20 0.51
PKM P14618 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
S1PR1 P21453 7/20 0.44
NR1H4 Q96RI1 2/20 0.44
HPGD P15428 2/20 0.44
S1PR3 Q99500 2/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 4/20 0.43
TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28633916 0.84 MAOA (0.46) NPC1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL3057263 0.83 NR1H4 (0.61) NPC1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL28636371 0.81 MAOA (0.44) NPC1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL5836424 0.81 NR1H4 (0.66) NPC1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL20968280 0.80 S1PR1 (0.48) NPC1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL28651999 0.79 S1PR1 (0.55) S1PR1S1PR3S1PR5
SCHEMBL28651748 0.79 MAOA (0.44) NPC1SMN1; SMN2HSD17B10NPSR1MAOA
SCHEMBL28638112 0.78 S1PR1 (0.44) MAOAMAOBS1PR1S1PR3MCHR1
Hydrochloric Acid SCHEMBL28647727 0.78 S1PR1 (0.43) MAOAMAOBS1PR1S1PR3MCHR1
SCHEMBL20968217 0.77 NPC1 (0.49) NPC1SMN1; SMN2HSD17B10NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662164-B2 Non-beta lactam antibiotics UNIVERSITY OF NOTRE DAME DU LAC (US) 2020-05-26 US disclosed
US-10662164-B2 Non-beta lactam antibiotics UNIVERSITY OF NOTRE DAME DU LAC (US) 2020-05-26 US disclosed
US-20190127340-A1 NON-BETA LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC 2019-05-02 US disclosed
US-20190127340-A1 NON-BETA LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC 2019-05-02 US disclosed
EP-3197888-A2 NON-BETA LACTAM ANTIBIOTICS University of Notre Dame du Lac (US) 2017-08-02 EP disclosed
WO-2016049586-A2 NON-BETA LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2016-03-31 WO disclosed
WO-2016049586-A2 NON-BETA LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662164-B2 Non-beta lactam antibiotics OXA1L, O60361, CUTA NPC1 2521/4885SMN1; SMN2 3703/4885HSD17B10 667/4885
US-20190127340-A1 NON-BETA LACTAM ANTIBIOTICS OXA1L, O60361, CUTA NPC1 2521/4885SMN1; SMN2 3703/4885HSD17B10 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.